Adicet Bio, Inc. financial data

Symbol
ACET on Nasdaq
Industry
Pharmaceutical Preparations
Location
131 Dartmouth Street, 3 Rd Floor, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
resTORbio, Inc. (to 8/21/2020)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.14K % -1.8%
Debt-to-equity 15.9 % +2.51%
Return On Equity -53.9 % +6.61%
Return On Assets -46.5 % +6.93%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.4M shares +90.9%
Common Stock, Shares, Outstanding 82.4M shares +91.2%
Entity Public Float 76.7M USD -82.1%
Common Stock, Value, Issued 8K USD +100%
Weighted Average Number of Shares Outstanding, Basic 90.8M shares +111%
Weighted Average Number of Shares Outstanding, Diluted 90.8M shares +111%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 101M USD -5.17%
General and Administrative Expense 27.6M USD +5.14%
Operating Income (Loss) -128M USD +15.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -118M USD +17.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -118M USD +17.6%
Earnings Per Share, Basic -1.7 USD/shares +49.4%
Earnings Per Share, Diluted -1.7 USD/shares +49.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 105M USD -42.4%
Other Assets, Current 543K USD +43.7%
Assets, Current 206M USD +11%
Property, Plant and Equipment, Net 24.1M USD -14.8%
Operating Lease, Right-of-Use Asset 15.1M USD -17.2%
Goodwill 0 USD -100%
Other Assets, Noncurrent 508K USD -44.5%
Assets 246M USD +5.45%
Accounts Payable, Current 2.5M USD -38.5%
Employee-related Liabilities, Current 6.1M USD +6.83%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 19.4M USD -1.89%
Operating Lease, Liability, Noncurrent 14.9M USD -20.1%
Other Liabilities, Noncurrent 116K USD -18.9%
Liabilities 34.4M USD -10.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 121K USD
Retained Earnings (Accumulated Deficit) -469M USD -33.6%
Stockholders' Equity Attributable to Parent 212M USD +8.66%
Liabilities and Equity 246M USD +5.45%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.8M USD +5.17%
Net Cash Provided by (Used in) Financing Activities 111M USD
Net Cash Provided by (Used in) Investing Activities -239K USD +87.5%
Common Stock, Shares Authorized 300M shares +100%
Common Stock, Shares, Issued 82.4M shares +91.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 87.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 105M USD -42.4%
Deferred Tax Assets, Valuation Allowance 99.1M USD +10.7%
Deferred Tax Assets, Gross 103M USD +8.24%
Operating Lease, Liability 18.2M USD -16.5%
Payments to Acquire Property, Plant, and Equipment 239K USD -87.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -30.4M USD +39.1%
Lessee, Operating Lease, Liability, to be Paid 22M USD
Property, Plant and Equipment, Gross 43.8M USD +5.66%
Operating Lease, Liability, Current 3.28M USD +4.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.84M USD -26.5%
Deferred Tax Assets, Operating Loss Carryforwards 65.6M USD -4.23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 18.5M USD +89.2%
Operating Lease, Payments 1.5M USD -31.8%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 4.66M USD +4.76%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 5.02M USD +16%
Deferred Tax Assets, Net of Valuation Allowance 3.68M USD -32.4%
Share-based Payment Arrangement, Expense 23.4M USD +19.3%
Operating Leases, Future Minimum Payments, Due in Three Years 4.01M USD -2.12%
Operating Leases, Future Minimum Payments Due 27M USD -2.15%
Interest Expense 4K USD -92%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%